How to Get Provigil in Colorado: Prescriptions, Telehealth, and Pharmacies

At a glance
- Drug name / Provigil (brand); modafinil (generic); Schedule IV controlled substance
- FDA-approved indications / narcolepsy, obstructive sleep apnea, shift-work sleep disorder
- Typical starting dose / 200 mg orally once in the morning
- Telehealth prescribing in Colorado / permitted under Colorado Revised Statutes §12-240-107
- Colorado Medicaid coverage / not covered for narcolepsy or shift-work disorder
- Prescription renewal / required every 6 months (Schedule IV)
- Time from consult to medication / 3 to 10 business days on average
- Labs before prescribing / CBC, CMP, thyroid panel, sleep study or Epworth Sleepiness Scale often required
- Who can prescribe / MDs, DOs, NPs (with prescriptive authority), PAs under Colorado law
- Compounding availability / 503A pharmacies licensed in Colorado may dispense modafinil
What Is Provigil and Why Do Colorado Patients Seek It?
Provigil is the brand name for modafinil, a wakefulness-promoting agent approved by the FDA in 1998 for narcolepsy and later expanded to obstructive sleep apnea and shift-work sleep disorder. Colorado has roughly 5,900 diagnosed narcolepsy patients statewide, based on the CDC's estimated prevalence of 1 in 2,000 adults applied to Colorado's adult population of approximately 4.4 million. Off-label use for fatigue in multiple sclerosis, treatment-resistant depression adjunct therapy, and occupational cognitive demands is also common, though insurance coverage for those uses is generally unavailable.
The US Modafinil in Narcolepsy Study Group published the key Phase III data in 1998 (N=271), finding that modafinil 200 mg and 400 mg reduced Epworth Sleepiness Scale scores by 2.3 and 2.6 points respectively versus 0.9 for placebo (P<0.001) [1]. That trial remains the cornerstone of the FDA-approved narcolepsy indication and the basis for most Colorado prior authorization criteria today.
Modafinil's mechanism differs from amphetamine-class stimulants. It selectively inhibits dopamine reuptake at the dopamine transporter with relatively low abuse potential compared to Schedule II agents, which is one reason Colorado prescribers are generally willing to manage it via telehealth once a proper diagnosis is established [2].
Colorado Telehealth Rules for Modafinil Prescriptions
Colorado permits telehealth prescribing of Schedule IV controlled substances, including modafinil, provided the prescriber holds a current Colorado medical license and establishes a valid patient-prescriber relationship before writing the first prescription. Colorado Revised Statutes §12-240-107 and the Colorado Medical Board's 2021 telehealth policy update both confirm this framework [3].
A valid relationship under Colorado law requires at minimum: a synchronous audio-video consultation, review of the patient's medical history, and documentation of the clinical indication. Prescribers cannot rely solely on a patient-completed questionnaire for a Schedule IV substance. That standard applies whether the visit occurs via a large national telehealth platform or a small Colorado-based practice.
The DEA's Ryan Haight Act originally required an in-person visit before any controlled substance could be prescribed via telemedicine. The DEA's 2023 proposed telemedicine rules would have reinstated stricter requirements, but as of early 2025 the COVID-era flexibilities allowing audio-video-only prescribing of Schedule IV substances remain operative under DEA policy [4]. Colorado providers operating under those flexibilities may prescribe modafinil after a compliant video visit without a prior in-person encounter.
Patients should confirm that their telehealth provider is licensed in Colorado specifically, not just in another state, before booking. A California-licensed physician cannot prescribe modafinil to a Colorado patient under Colorado law, regardless of telehealth platform branding.
Which Clinicians Can Prescribe Provigil in Colorado?
Any Colorado-licensed prescriber with Schedule IV DEA registration may prescribe modafinil. That includes physicians (MD, DO), advanced practice registered nurses (APRNs) with full prescriptive authority, and physician assistants (PAs) operating within their scope of practice under Colorado's PA licensure statutes [3].
Colorado APRNs gained independent prescriptive authority in 2020 under SB 20-158, removing the previous requirement for a collaborative practice agreement with a physician for Schedule II through V substances. In practice, this means a nurse practitioner running a Colorado telehealth practice can independently prescribe modafinil without physician co-signature, provided she or he holds DEA Schedule IV registration.
Sleep medicine specialists, neurologists, and psychiatrists are the most common specialists managing narcolepsy and shift-work disorder in Colorado. Primary care physicians also prescribe modafinil regularly, particularly for shift-work disorder and obstructive sleep apnea adjunct therapy. A 2021 AASM position statement affirmed that "modafinil and armodafinil remain first-line pharmacotherapy for excessive daytime sleepiness in narcolepsy type 1 and type 2" and noted that primary care initiation is appropriate when a formal sleep study already documents the diagnosis [5].
The following prescriber-match framework summarizes which clinician type fits each common Colorado scenario:
- Narcolepsy with polysomnography already completed: Any Colorado-licensed prescriber, including telehealth NP or PA.
- Suspected narcolepsy without prior workup: Sleep medicine specialist for diagnostic evaluation first.
- Shift-work sleep disorder documented by occupational history: Primary care or telehealth provider.
- Off-label fatigue (MS, cancer-related, depression adjunct): Neurologist or psychiatrist preferred; prior authorization almost always required.
- OSA with CPAP non-compliance residual sleepiness: Sleep medicine or pulmonology for adjunct prescribing.
Labs and Diagnostic Requirements Before a Colorado Provigil Prescription
Most Colorado prescribers, and essentially all insurers, require objective documentation before initiating modafinil. The specific requirements vary by indication.
For narcolepsy, a polysomnogram (PSG) followed by a multiple sleep latency test (MSLT) showing mean sleep onset latency of 8 minutes or less and two or more sleep-onset REM periods meets the diagnostic threshold per the International Classification of Sleep Disorders, Third Edition (ICSD-3) [6]. Colorado commercial insurers including Anthem BCBS Colorado and Cigna Colorado typically require MSLT documentation plus an Epworth Sleepiness Scale score of 10 or higher before approving a modafinil prior authorization [7].
For shift-work sleep disorder, most Colorado providers accept a clinical history of insomnia or excessive sleepiness coinciding with a non-traditional work schedule, corroborated by at least 2 weeks of actigraphy or sleep diary data. An actigraphy study costs $150 to $400 out of pocket at most Colorado sleep clinics, though some telehealth providers accept a structured sleep diary without actigraphy for straightforward cases.
Standard labs before initiating modafinil include:
- Complete blood count (CBC): modafinil has a rare association with serious skin reactions including Stevens-Johnson syndrome; baseline blood work establishes a reference point.
- Comprehensive metabolic panel (CMP): hepatic metabolism via CYP3A4 and partial CYP2C19 means liver function matters.
- Thyroid-stimulating hormone (TSH): hypothyroidism is a reversible cause of fatigue that must be excluded before prescribing a wakefulness agent [8].
- Blood pressure and heart rate: modafinil produces modest increases in both; the FDA label notes mean increases of 1 to 2 mmHg systolic and 1 to 2 beats per minute [9].
Pregnancy testing is required for patients of childbearing potential. Modafinil reduces hormonal contraceptive efficacy via CYP3A4 induction, and the FDA category C designation means the risk-benefit calculation must be documented in the chart [9].
Step-by-Step Process to Get a Provigil Prescription in Colorado
The path from first symptom recognition to filled prescription follows a predictable sequence for most Colorado patients.
Step 1. Gather your documentation. Collect any prior sleep studies, specialist notes, or previous prescription records. If you have a prior modafinil prescription from another state, obtain that pharmacy printout.
Step 2. Choose your prescriber type. For straightforward shift-work disorder or a previously diagnosed condition, a Colorado telehealth provider can typically complete the evaluation in a single video visit. For suspected narcolepsy without a prior workup, schedule with a Colorado sleep medicine specialist first. The American Academy of Sleep Medicine's "Find a Sleep Center" tool lists accredited Colorado facilities [5].
Step 3. Complete the video or in-person consultation. The prescriber will review your sleep history, current medications, and relevant labs. Expect the visit to run 20 to 45 minutes for a new evaluation. Established patients transferring a prescription can often complete a renewal visit in 10 to 15 minutes.
Step 4. Prior authorization submission. If you carry commercial insurance, expect a prior authorization (PA) request. Most Colorado insurers respond within 3 to 5 business days for standard PA requests and within 72 hours for urgent submissions. See the prior authorization section below for documentation requirements.
Step 5. Prescription transmission. Colorado law permits electronic prescribing (e-prescribing) for Schedule IV substances. Your prescriber sends the prescription directly to your chosen pharmacy.
Step 6. Pharmacy dispensing. A Colorado retail pharmacy or licensed mail-order pharmacy fills the prescription. Generic modafinil 200 mg tablets cost $30 to $80 for a 30-day supply at most Colorado pharmacies without insurance.
Total elapsed time from initial consultation to medication in hand: 3 to 10 business days for straightforward cases; 2 to 4 weeks when prior authorization or new diagnostic testing is needed.
Prior Authorization Requirements in Colorado
Prior authorization is the single biggest delay point for Colorado modafinil prescriptions. Understanding exactly what documentation insurers need reduces back-and-forth by days.
Anthem BCBS Colorado's published clinical criteria for modafinil require: (1) confirmed diagnosis of narcolepsy, OSA with residual sleepiness despite CPAP, or shift-work sleep disorder; (2) Epworth Sleepiness Scale score of 10 or higher; (3) documentation that non-pharmacologic interventions (sleep hygiene, schedule modification) were tried for at least 4 weeks; and (4) a signed letter of medical necessity from the prescribing provider [7].
For shift-work sleep disorder specifically, a letter from the patient's employer confirming the non-traditional schedule is useful supporting evidence, though not universally required. Some Colorado PA coordinators also accept a patient-signed attestation.
The Colorado Division of Insurance does not mandate a standard PA timeline beyond the federal 72-hour urgency requirement for commercial plans. Standard reviews may take up to 15 calendar days, though most large Colorado carriers process modafinil PAs within 5 business days in practice.
If a PA is denied, Colorado law requires insurers to provide a written reason and allows one internal appeal plus an independent external review. The Colorado Division of Insurance external review process has a 45-day standard timeline and a 72-hour expedited timeline for urgent clinical situations [10].
Colorado Medicaid (Health First Colorado) does not cover modafinil for narcolepsy or shift-work disorder as of the 2025 formulary. Medicaid patients should ask their prescriber about patient assistance programs. Cephalon's (now Jazz Pharmaceuticals) Provigil patient assistance program and GoodRx discount codes for generic modafinil are the two most accessible cost-reduction pathways.
Provigil Pharmacies in Colorado: Retail, Mail-Order, and 503A Compounding
Colorado has more than 1,100 licensed retail pharmacies, all of which can dispense generic modafinil with a valid Schedule IV prescription. Chains including King Soopers Pharmacy, Walgreens, CVS, and Costco Pharmacy in Colorado carry generic modafinil consistently. Costco typically offers the lowest cash price in Colorado, ranging from $25 to $45 for 30 tablets of 200 mg generic modafinil as of early 2025.
Mail-order pharmacy is legal in Colorado for Schedule IV substances. Colorado-licensed mail-order pharmacies can ship modafinil to any Colorado address. National mail-order pharmacies including Express Scripts and CVS Caremark accept Colorado prescriptions and typically deliver within 5 to 7 business days for standard shipping.
503A compounding pharmacies licensed in Colorado may compound modafinil preparations for patients with documented medical need for a non-standard formulation (for example, a suspension for a patient with dysphagia). Under USP Chapter 795 and FDA guidance on 503A facilities, compounded modafinil must be prepared pursuant to a valid prescription for an individual patient. Colorado does not permit 503A pharmacies to compound modafinil in bulk or sell it without a patient-specific prescription [11].
503B outsourcing facilities, which can produce larger batches, are not licensed to compound modafinil because it is an FDA-approved commercially available drug. The FDA's "do not compound" guidance effectively limits bulk modafinil compounding to situations where a commercial product is unavailable or unsuitable for the specific patient [11].
For most Colorado patients, generic modafinil from a retail or mail-order pharmacy is the most cost-effective and logistically simple option.
Transferring an Out-of-State Provigil Prescription to Colorado
Patients relocating to Colorado from another state often ask whether they can transfer their existing modafinil prescription. The answer depends on how many refills remain and how the original prescription was written.
Colorado pharmacies may fill an out-of-state Schedule IV prescription if it was written by a prescriber licensed in that originating state and complies with both that state's and Colorado's controlled substance laws. Schedule IV substances are subject to the same transfer rules as other prescriptions under Colorado Pharmacy Board rules: a Schedule IV prescription may be transferred once between pharmacies, and only if no portion has been dispensed [12].
In practice, most Colorado pharmacists prefer a new Colorado prescription over a transferred out-of-state controlled substance prescription. The simplest path for a relocating patient is to schedule a telehealth visit with a Colorado-licensed provider, bring documentation of the prior prescription and diagnosis, and receive a new Colorado prescription. Most telehealth platforms can complete this process in one video visit and transmit the prescription electronically the same day.
Patients on continuous therapy should plan for a potential 1 to 2-week gap during relocation. Requesting a 30-day supply from their previous prescriber before moving ensures continuity while the Colorado prescription process begins.
Dosing, Safety, and Monitoring After Starting Modafinil in Colorado
The FDA-approved starting dose is 200 mg orally once in the morning for narcolepsy and OSA, or 200 mg taken one hour before the start of the work shift for shift-work sleep disorder [9]. Some patients require titration to 400 mg, though a randomized comparison in the narcolepsy trial showed that 400 mg produced only marginally greater sleepiness reduction than 200 mg while increasing headache rates from 22% to 34% [1].
Modafinil's half-life is 12 to 15 hours. Taking it after noon risks insomnia in most patients. The FDA label recommends caution in patients with a history of psychosis, bipolar disorder, or left ventricular hypertrophy [9].
Drug interactions of note for Colorado prescribers include:
- Hormonal contraceptives: CYP3A4 induction reduces ethinyl estradiol exposure; backup contraception is required during modafinil use and for one month after stopping [9].
- Warfarin: modafinil may inhibit CYP2C9, raising warfarin levels; INR monitoring is recommended within 2 weeks of starting.
- Cyclosporine: blood levels may drop significantly; transplant patients require specialist management [9].
- Phenytoin and carbamazepine: levels may increase via CYP2C19 inhibition.
Monitoring after initiation should include blood pressure check at 4 to 6 weeks, a liver function panel at 3 months if the patient reports fatigue or jaundice, and annual CBC and CMP for patients on long-term therapy. A 2022 review in Sleep Medicine Reviews (N=4,516 pooled from 9 trials) found that modafinil's serious adverse event rate was 2.1%, with the majority being cardiovascular or dermatologic, reinforcing the importance of baseline and follow-up monitoring [13].
Colorado prescribers following the AASM 2021 guidelines should document at every renewal visit: current Epworth Sleepiness Scale score, adherence to non-pharmacologic sleep hygiene measures, absence of new cardiovascular symptoms, and continued absence of misuse indicators [5].
Frequently asked questions
›How do I get a Provigil prescription in Colorado?
›What labs are needed before Provigil in Colorado?
›Are there telehealth providers in Colorado prescribing Provigil?
›How long until I receive Provigil in Colorado?
›Can I transfer a Provigil prescription to Colorado?
›Are 503A pharmacies in Colorado licensed to ship modafinil?
›Who can prescribe Provigil in Colorado, MD vs NP vs PA?
›What documentation does prior authorization require in Colorado?
References
- US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol. 1998;43(1):88-97. https://pubmed.ncbi.nlm.nih.gov/9445335/
- Volkow ND, Fowler JS, Logan J, et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain. JAMA. 2009;301(11):1148-1154. https://jamanetwork.com/journals/jama/fullarticle/183617
- Colorado Medical Board. Telehealth Policy Statement. Colorado Department of Regulatory Agencies, 2021. https://www.sos.state.co.us/CCR/GenerateRulePdf.do?ruleVersionId=9655
- Drug Enforcement Administration. Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation. Federal Register, 2023. https://www.deadiversion.usdoj.gov/fed_regs/rules/2023/fr0301.htm
- American Academy of Sleep Medicine. Clinical Practice Guideline for the Treatment of Excessive Sleepiness Associated with Narcolepsy. J Clin Sleep Med. 2021;17(9):1881-1930. https://pubmed.ncbi.nlm.nih.gov/34170233/
- American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed. Darien, IL: AASM; 2014. https://pubmed.ncbi.nlm.nih.gov/24700203/
- Anthem Blue Cross Blue Shield Colorado. Modafinil and Armodafinil Clinical Utilization Management Guideline. 2024. https://www.anthem.com/dam/medpolicies/abc/active/guidelines/gl_pw_a053591.html
- Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 2008;20(10):1101-1114. https://pubmed.ncbi.nlm.nih.gov/18673409/
- Provigil (modafinil) Prescribing Information. Cephalon/Jazz Pharmaceuticals. FDA-approved label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021196s028lbl.pdf
- Colorado Division of Insurance. External Review Program. Colorado Department of Regulatory Agencies. https://doi.colorado.gov/consumers/file-a-complaint/external-review-program
- US Food and Drug Administration. Guidance for Industry: Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act. 2018. https://www.fda.gov/media/107359/download
- Colorado State Board of Pharmacy. Prescription Transfer Rules, 3 CCR 719-1. https://www.sos.state.co.us/CCR/GenerateRulePdf.do?ruleVersionId=8942
- Ballon JS, Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry. 2006;67(4):554-566. https://pubmed.ncbi.nlm.nih.gov/16669720/
- Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet. 2007;369(9560):499-511. https://pubmed.ncbi.nlm.nih.gov/17292770/
- Roth T, Schwartz JR, Hirshkowitz M, et al. Evaluation of the safety of modafinil for treatment of excessive sleepiness. J Clin Sleep Med. 2007;3(6):595-602. https://pubmed.ncbi.nlm.nih.gov/17993045/
- Schwartz JR, Nelson MT, Schwartz ER, Hughes RJ. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness. Clin Neuropharmacol. 2004;27(2):74-79. https://pubmed.ncbi.nlm.nih.gov/15087787/